((自动化翻译由路透提供，请见免责声明 ))
路透10月21日 - 康泰伦特 总裁兼首席执行官亚历山德罗-马塞利（Alessandro Maselli）周一表示，在减肥药生产商诺和诺德 的控股股东诺和诺德控股公司收购康泰伦特后，他将继续领导这家合同药品生产商。
马塞利的公开信是在对诺和诺德收购康泰伦特的批评日益增多的背景下发出的，该收购可能威胁到减肥药和尖端基因疗法领域的竞争。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.